Advances in hematology testing offer parameters useful in assessing challenging conditions such as thrombocytopenia. This presentation provides an overview of immature platelet parameters (IPF% and IPF#) and discusses their clinical utility. Case studies will be presented to highlight the value of these parameters in assessing bone marrow activity and effective thrombopoiesis.
This presentation takes an in depth look at the function of lymphoid cells, describes their role in immunologic response, and outlines the impact to normal and abnormal processes. In addition, plasma cells and plasma cell myeloma will be reviewed using case studies to highlight ensuing patient conditions and associated findings.
This session will review the incidence, clinical significance, and diagnostic evaluation of anemia, iron deficiency and thrombocytopenia in neonates.
This presentation will explore how one institution was able to make effective use of the Advanced Hematology Parameters that include Immature Granulocytes (IG), Reticulocyte Hemoglobin (RET-He), and Immature Platelet Fraction (IPF).
This presentation reviews newer hematology analyzers that analyze thousands of leukocytes using flow cytometric based methodology, some in combination with cytochemistry or fluorescence or conductivity to elucidate different types of white cells, NRBCs, and in some cases immature granulocytes
Discussing testing that occurs downstream of the CBC report when a diagnosis of hematologic neoplasia such as leukemia, lymphoma, and myelodysplasia is suspected.